Description

Mechanism of Action

Dual Incretin Activation: Simultaneously stimulates GLP-1 and GIP receptors, enhancing
glucose-dependent insulin secretion and suppressing inappropriate glucagon release.
Appetite and Satiety Regulation: Delays gastric emptying and acts on central appetite centers
to reduce caloric intake and support weight management.
Metabolic Efficiency: Promotes improved postprandial glucose control and overall energy
balance.
Muscle and Body Composition Support: When paired with amino acids and key nutrients like
glycine and B12, tirzepatide contributes to balanced body composition and sustained metabolic
health.
LP-1/GIP represents an advanced approach to metabolic optimization, offering
comprehensive support for glucose control, weight management, and long-term metabolic
performance.

Key Benefits

• Dual Incretin Effect: Tirzepatide activates both GIP and GLP-1 receptors, enhancing insulin
  secretion, improving glucose regulation, and reducing appetite.
• Sustained Weight Reduction: Promotes significant weight loss through combined appetite
  suppression and improved metabolic efficiency.
• Lean Muscle Preservation: Glycine supports muscle maintenance during weight loss and
  metabolic optimization programs.
• Improved Glycemic Stability: Enhances fasting and postprandial glucose control more robustly
  than GLP-1 monotherapy.
• Comprehensive Metabolic Support: Supports insulin sensitivity, body composition, and energy
  utilization.
• Convenient Dosing: Once-weekly administration improves adherence and patient
  convenience.